RI-MUHC trainee receives oral presentation prize from Canadian Conference on Ovarian Cancer Research

Doctoral student Wejdan Alenezi proposes new genes to predict ovarian cancer risk Wejdan Alenezi, a doctoral candidate in human genetics at McGill University...
June 28, 2022

Taking opioids at home after surgery: More harms than benefits

A new study conducted at the RI-MUHC concludes that prescribing opioid analgesics at discharge after surgery does not reduce postoperative pain and increases...
June 28, 2022

Giving teens with MS more treatment options

The first ever pediatric trial at The Neuro hopes to broaden the limited options for young people with Multiple Sclerosis We often think...
June 16, 2022

Climate Wise: Medical students lead development of evidence-based tool to integrate planetary health into medical curricula

Deemed the greatest threat to global health of the 21st century by the World Health Organization, climate change and its effects on human...
June 8, 2022

New study: Montreal researchers identify three drugs that could reduce mortality in severely ill COVID-19 patients

Researchers from the RI-MUHC and the McGill Genome Centre examine differences in ICU patients who recovered or died from COVID-19 and identify candidate...
June 8, 2022

New study reveals impact of COVID-19 pandemic on Quebec’s nurses

During the first wave of the COVID-19 pandemic, researcher and Professor Céline Gélinas believed it was important to survey Quebec nursing staff to...
June 8, 2022

McGill supports clinical innovation, one CLIC at a time

On May 10, the McGill community gathered virtually to celebrate innovation during the Fifth Annual McGill Clinical Innovation Competition (CLIC). Inspired by founding...
June 6, 2022

McGill team uncovers root causes of neuropathic pain

Discovery of underlying mechanism behind the debilitating and difficult to treat nerve condition could lead to new therapies Neuropathic pain is a common...
June 6, 2022

Shedding light on Parkinson’s toward new treatments and cures

An observational study led by The Michael J. Fox Foundation is looking for people recently diagnosed with Parkinson’s, and those with risk factors,...
June 6, 2022

4 Burning Questions for…. Steffanie Strathdee, AMR Symposium keynote speaker

On June 20, Steffanie Strathdee, PhD, will deliver the keynote address at the second Annual McGill Antimicrobial Resistance (AMR) Symposium, titled Superbugged: The...
June 3, 2022

Bacteriophages and innovations in antimicrobial therapeutics at the 2nd Annual AMR Symposium

On Monday, June 20, 2022, the McGill Antimicrobial Resistance (AMR) Centre will host its second annual symposium, both in-person at the McGill University...
June 3, 2022

Q&A with Dr. Natasha Rajah and Jamie Snytte – exploring normal and pathological aging of the brain

Dr. Natasha Rajah is a researcher at the Douglas Research Centre and a Professor in the Department of Psychiatry at McGill University. She...
May 26, 2022